Table of Contents - store.pda.org - Parenteral Drug Association
Table of Contents - store.pda.org - Parenteral Drug Association
Table of Contents - store.pda.org - Parenteral Drug Association
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
8.4 Routine Monitoring......................................... 66<br />
8.5 Data Trending and Review.............................. 66<br />
8.6 Evaluation <strong>of</strong> Cumulative Changes.................. 67<br />
8.7 Training........................................................... 67<br />
8.8 Periodic Review.............................................. 67<br />
9.0 Documentation....................................................69<br />
9.1 Cleaning Validation Master Plans................... 69<br />
9.1.1 Elements <strong>of</strong> a Comprehensive Plan..... 70<br />
9.1.2 Harmonization <strong>of</strong> Site Cleaning<br />
Validation Programs ........................... 71<br />
9.2 Documentation for Design/Development........ 71<br />
9.3 Documentation for Qualification..................... 72<br />
9.4 Documentation for Validation Maintenance.... 72<br />
9.5 Other Documentation Considerations............. 73<br />
10.0 Special Considerations.....................................75<br />
10.1 Cleaning Agents...................................... 75<br />
10.1.1 Types.................................................. 75<br />
10.1.1.1 Water.............................................. 75<br />
10.1.1.2 Organic Solvents............................. 75<br />
10.1.1.3 Commodity Alkali............................ 75<br />
10.1.1.4 Commodity Acids........................... 75<br />
10.1.1.5 Formulated Detergents.................... 75<br />
10.1.2 Factors in Selection............................ 76<br />
10.1.2.1 Broad Spectrum Effectiveness........ 76<br />
10.1.2.2 Substrate Compatibility.................. 76<br />
10.1.2.3 Stability and Shelf Life.................... 76<br />
10.1.2.4 Analyzability.................................... 76<br />
10.1.2.5 Disposal.......................................... 76<br />
10.1.2.6 Safety............................................. 76<br />
10.1.2.7 Toxicity........................................... 76<br />
10.1.2.8 Rinsability....................................... 76<br />
10.1.2.9 Quality............................................. 76<br />
10.2 Nonproduct Contact Surfaces.................. 76<br />
10.3 Process Analytical Technology................ 77<br />
10.3.1 Timely Measurements........................ 77<br />
10.3.2 PAT for Cleaning Process Control........ 77<br />
10.3.3 Additional Considerations for Online<br />
Measurements................................... 78<br />
10.4 Clean Hold Considerations....................... 78<br />
10.5 New and Used Equipment....................... 80<br />
10.5.1 New Equipment................................... 80<br />
10.5.1.1 Cleaning Procedure Development... 80<br />
10.5.1.2 Post-Installation Cleaning................ 81<br />
10.5.1.3 Grouping Impact............................... 81<br />
10.5.1.4 Limit Calculation Impact................... 81<br />
10.5.2 Used Equipment................................. 81<br />
10.6 Measurement Systems Analysis (MSA) .81<br />
10.6.1 MSA Components.............................. 82<br />
10.6.2 Attribute R&R..................................... 82<br />
10.6.3 Minimizing Variations......................... 82<br />
10.6.4 MSA and Cleaning<br />
Validation Strategy............................. 82<br />
10.7 Cleaning for API Manufacture.................. 83<br />
10.8 Topical <strong>Drug</strong> Products.............................. 84<br />
10.8.1 Topical <strong>Drug</strong> Products with<br />
Systemic Availability.......................... 84<br />
10.8.2 Topical <strong>Drug</strong> Products with No or<br />
Limited Systemic Availability............. 85<br />
10.8.2.1 Adjusted Calculation....................... 85<br />
10.8.2.2 Modification Based on<br />
Frequency <strong>of</strong> Application................ 85<br />
10.8.2.3 Modification Based on Amount<br />
Applied per Surface Area................ 85<br />
10.8.2.4 Additional Considerations............... 86<br />
10.8.3 Additional Safety Considerations........ 86<br />
10.8.4 Additional Cleaning Considerations.... 86<br />
10.9 Animal <strong>Drug</strong> Products.............................. 86<br />
10.10 Packaging Components and<br />
Packaging Equipment................................ 86<br />
10.10.1 Primary Packaging Components........ 86<br />
10.10.1.1 Oral Dosage Forms Primary<br />
Packaging Components................. 87<br />
10.10.1.2 <strong>Parenteral</strong> Dosage Forms Primary<br />
Packaging Components................. 87<br />
10.10.2 Packaging Equipment........................ 87<br />
10.10.2.1 Primary Packaging Equipment....... 87<br />
10.10.2.2 Secondary Packaging Equipment.. 88<br />
10.11 Tubing and Hoses.................................... 88<br />
10.12 Excipients................................................ 89<br />
10.13 Dedicated Equipment............................... 89<br />
10.13.1 Reasons for Dedication...................... 89<br />
10.13.2 Cleaning Validation Issues................. 90<br />
11.0 Regulatory and Guidance Documents..............91<br />
12.0 References........................................................92<br />
13.0 Suggested Readings.........................................94<br />
www.<strong>pda</strong>.<strong>org</strong>/book<strong>store</strong>